CORMORANT ASSET MANAGEMENT, LP – Apellis Pharmaceuticals, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$100.94M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +55.58% | 528K shares | 57.98M | $68.3 | 1.47M |
| Q2 2022 | share | Decrease | -15.56% | -175K shares | -14.20M | $45.22 | 950K |
| Q1 2022 | share | Increase | +80.00% | 500K shares | 27.61M | $50.81 | 1.12M |
| Q4 2021 | share | Decrease | -32.43% | -300K shares | -938K | $47.95 | 625K |
| Q3 2021 | share | Increase | +8.82% | 75K shares | -23.23M | $32.96 | 925K |
| Q2 2021 | share | Decrease | -54.45% | -1.01M shares | -26.35M | $63.2 | 850K |
| Q1 2021 | share | 0.00% | 0 shares | -26.66M | $42.91 | 1.86M | |
| Q4 2020 | share | 0.00% | 0 shares | 50.44M | $57.2 | 1.86M | |
| Q3 2020 | share | Decrease | -9.68% | -200K shares | -11.17M | $30.17 | 1.86M |
| Q2 2020 | share | Decrease | -8.83% | -200K shares | 6.77M | $32.66 | 2.06M |
| Q1 2020 | share | Decrease | -16.07% | -433.89K shares | -21.96M | $26.79 | 2.26M |
| Q4 2019 | share | Decrease | -9.27% | -276K shares | 10.98M | $30.62 | 2.7M |
| Q3 2019 | share | Increase | +0.33% | 9.89K shares | -3.46M | $24.09 | 2.97M |
| Q2 2019 | share | Decrease | -17.61% | -633.89K shares | 4.96M | $25.34 | 2.96M |
| Q1 2019 | share | Decrease | -20.04% | -902.49K shares | 10.81M | $19.5 | 3.6M |
| Q4 2018 | share | Increase | +7.91% | 330K shares | -14.79M | $13.19 | 4.50M |
| Q3 2018 | share | Decrease | -3.25% | -140K shares | -20.68M | $17.78 | 4.17M |
| Q2 2018 | share | Increase | +5.49% | 224.26K shares | 4.48M | $22 | 4.31M |
| Q1 2018 | share | Increase | +8.48% | 319.47K shares | 8.60M | $22.11 | 4.08M |
| Q4 2017 | share | Increase | 0.00% | 3.76M shares | 81.78M | $21.7 | 3.76M |